The therapeutic strategy of selectively targeting and altering the behavior or presence of senescent cells, often referred to as “zombie cells,” which accumulate in tissues with age. Modulation can involve senolytics, which induce the death of these cells, or senomorphics, which alter their destructive secretory phenotype (SASP). This process is critical because senescent cells drive chronic inflammation and contribute significantly to tissue dysfunction and aging-related diseases.
Origin
This concept is a cornerstone of geroscience and longevity research, stemming from the discovery of cellular senescence as a key driver of aging pathology. “Senescent Cell” refers to the non-dividing, metabolically active cell that secretes pro-inflammatory factors, and “Modulation” is the clinical effort to control their detrimental impact. It represents a direct intervention into the biological mechanisms of aging.
Mechanism
Modulation works by interrupting the pro-survival pathways that keep senescent cells alive, leading to their programmed elimination via apoptosis. Alternatively, senomorphics target the Senescence-Associated Secretory Phenotype (SASP), reducing the secretion of inflammatory cytokines, chemokines, and matrix metalloproteinases. By clearing or silencing these cells, the tissue microenvironment is rejuvenated, allowing for improved tissue function and reduced systemic inflammation.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.